{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:44:13Z","timestamp":1777394653296,"version":"3.51.4"},"reference-count":46,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.3233\/jad-160241","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T03:42:57Z","timestamp":1472269377000},"page":"1073-1084","source":"Crossref","is-referenced-by-count":24,"title":["CerefolinNAC Therapy of\u00a0Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer\u2019s Disease and Cerebrovascular Disease"],"prefix":"10.1177","volume":"54","author":[{"given":"William R.","family":"Shankle","sequence":"first","affiliation":[{"name":"Medical Care Corporation, Newport Beach, CA, USA"},{"name":"Shankle Clinic, Newport Beach, CA, USA"},{"name":"Memory and Cognitive Disorders Program, Neurosciences Institute, Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA"},{"name":"Department of Cognitive Sciences, University of California, Irvine, Irvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Hara","sequence":"additional","affiliation":[{"name":"Medical Care Corporation, Newport Beach, CA, USA"},{"name":"Shankle Clinic, Newport Beach, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori W.","family":"Barrentine","sequence":"additional","affiliation":[{"name":"Nestl\u00e9 Health Science \u2013 Pamlab, Inc., Covington, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie V.","family":"Curole","sequence":"additional","affiliation":[{"name":"Nestl\u00e9 Health Science \u2013 Pamlab, Inc., Covington, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160241_ref1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3945\/ajcn.111.020230","article-title":"Vitamin B-12 and homocysteine status in a folate-replete population: Results from the Canadian Health Measures Survey","volume":"94","author":"MacFarlane","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JAD-160241_ref2","first-page":"117","article-title":"Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification","volume":"28","author":"Selhub","year":"2000","journal-title":"Public Health Rev"},{"key":"10.3233\/JAD-160241_ref3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/gerona\/gls211","article-title":"Homocysteine, frailty, and all-cause mortality in older men: The Health in Men Study","volume":"68","author":"Wong","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-160241_ref4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","article-title":"Hyperhomocysteinemia and neurologic disorders: A review","volume":"10","author":"Ansari","year":"2014","journal-title":"J Clin Neurol"},{"key":"10.3233\/JAD-160241_ref5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jalz.2011.11.008","article-title":"Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study","volume":"9","author":"Jochemsen","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160241_ref6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3233\/JAD-130956","article-title":"Serum folate, homocysteine, brain atrophy, and auto-CM system: The Treviso Dementia (TREDEM) study","volume":"38","author":"Gallucci","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160241_ref7","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160241_ref8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/07315724.2007.10719611","article-title":"Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients","volume":"26","author":"Yang","year":"2007","journal-title":"J Am Coll Nutr"},{"key":"10.3233\/JAD-160241_ref9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12603-012-0051-y","article-title":"Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the VITA cohort","volume":"16","author":"Blasko","year":"2007","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-160241_ref10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ajcn\/86.3.728","article-title":"Plasma folate concentration and cognitive performance: Rotterdam Scan Study","volume":"86","author":"de Lau","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JAD-160241_ref11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI106609","article-title":"Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate","volume":"50","author":"Levitt","year":"1971","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-160241_ref12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01800658","article-title":"Clinical role of pteridine therapy in tetrahydrobiopterin deficiency","volume":"8","author":"Smith","year":"1985","journal-title":"J Inherit Metab Dis"},{"key":"10.3233\/JAD-160241_ref13","first-page":"319","article-title":"Impact of hyperhomocysteinemia treatment on cognitive decline due to Alzheimer\u2019s disease and related disorders","volume":"2","author":"Shankle","year":"2013","journal-title":"J Aging Res Clin Pract"},{"key":"10.3233\/JAD-160241_ref14","doi-asserted-by":"crossref","unstructured":"Hara J , Shankle WR , Barrentine LW , Curole MV (2016) Novel therapy of hyperhomocysteinemia in mild cognitive impairment, Alzheimer\u2019s disease, and other dementing disorders. J Nutr Health Aging 10.1007\/s12603-016-0688-z","DOI":"10.1007\/s12603-016-0688-z"},{"key":"10.3233\/JAD-160241_ref15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ana.10440","article-title":"Homocysteine, white matter hyperintensities, and cognition in healthy elderly people","volume":"53","author":"Dufouil","year":"2003","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160241_ref16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2004.09.006","article-title":"Homocysteine, cerebrovascular disease and brain atrophy","volume":"226","author":"Sachdev","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160241_ref17","first-page":"30","article-title":"Dementia: A systematic approach to identifying reversible causes","volume":"41","author":"Reisberg","year":"1986","journal-title":"Geriatrics"},{"key":"10.3233\/JAD-160241_ref18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial","volume":"27","author":"de Jager","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-160241_ref19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jagp.2012.10.017","article-title":"Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults","volume":"21","author":"Feng","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-160241_ref20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000000168","article-title":"Homocysteine and progression of generalized small-vessel disease: The SMART-MR Study","volume":"82","author":"Kloppenborg","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-160241_ref21","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1212\/WNL.0b013e3182749f39","article-title":"Incident subcortical infarcts induce focal thinning in connected cortical regions","volume":"79","author":"Duering","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-160241_ref22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.metabol.2004.09.015","article-title":"Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia","volume":"54","author":"Doshi","year":"2005","journal-title":"Metabolism"},{"key":"10.3233\/JAD-160241_ref23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2014.03.040","article-title":"Critical levels of brain atrophy associated with homocysteine and cognitive decline","volume":"35","author":"de Jager","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160241_ref24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1749-6632.2001.tb05830.x","article-title":"Plasticity of the hippocampus: Adaptation to chronic stress and allostatic load","volume":"933","author":"McEwen","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-160241_ref25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pmr.2011.11.001","article-title":"Hypohomocysteinemia: A potentially treatable cause of peripheral neuropathology?","volume":"23","author":"Cullen","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.3233\/JAD-160241_ref26","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial","volume":"300","author":"Aisen","year":"2008","journal-title":"JAMA"},{"key":"10.3233\/JAD-160241_ref27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF02982630","article-title":"Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: Critical role of S-adenosyl methionine","volume":"12","author":"Chan","year":"2008","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-160241_ref28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.conb.2006.09.002","article-title":"The role of acetylcholine in learning and memory","volume":"16","author":"Hasselmo","year":"2006","journal-title":"Curr Opin Neurobiol"},{"key":"10.3233\/JAD-160241_ref29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2011.03.065","article-title":"Akt\/mammalian target of rapamycin signaling pathway regulates neurite outgrowth in cerebellar granule neurons stimulated by methylcobalamin","volume":"495","author":"Okada","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160241_ref30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s12035-014-8705-x","article-title":"The glutathione system: A new drug target in neuroimmune disorders","volume":"50","author":"Morris","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-160241_ref31","unstructured":"(2000) N-acetylcysteine. Altern Med Rev 5, 467\u2013471."},{"key":"10.3233\/JAD-160241_ref32","unstructured":"(2001) Glutathione, reduced. (GSH). Altern Med Rev 6, 601\u2013607."},{"key":"10.3233\/JAD-160241_ref33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2005.03.054","article-title":"Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture","volume":"1046","author":"Jayalakshmi","year":"2005","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160241_ref34","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/npp.2011.109","article-title":"N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72\/G30 transgenic mice","volume":"36","author":"Otte","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-160241_ref35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/pr.2013.40","article-title":"N-acetyl-cysteine prevents pyramidal cell disarray and reelin-immunoreactive neuron deficiency in CA3 after prenatal immune challenge in rats","volume":"73","author":"Rideau Batista Novais","year":"2013","journal-title":"Pediatr Res"},{"key":"10.3233\/JAD-160241_ref36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuint.2012.06.001","article-title":"Rescue from a two hit, high-throughput model of neurodegeneration with N-acetyl cysteine","volume":"61","author":"Unnithan","year":"2012","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-160241_ref37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JAD-142499","article-title":"A phase II randomized clinical trial of a nutritional formulation for cognition and mood in Alzheimer\u2019s disease","volume":"45","author":"Remington","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160241_ref38","doi-asserted-by":"crossref","first-page":"e54163","DOI":"10.1371\/journal.pone.0054163","article-title":"Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: A double-blind, placebo controlled study","volume":"8","author":"Hoffer","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160241_ref39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fct.2013.09.015","article-title":"Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against A\u03b2(25-35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals","volume":"62","author":"Chen","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.3233\/JAD-160241_ref40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-2010-1396","article-title":"Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer\u2019s disease transgenic model","volume":"20","author":"Chen","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160241_ref41","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.clinthera.2007.10.012","article-title":"Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer\u2019s disease: A 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients","volume":"29","author":"Sun","year":"2007","journal-title":"Clin Ther"},{"key":"10.3233\/JAD-160241_ref42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gps.1856","article-title":"A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer\u2019s disease","volume":"23","author":"Connelly","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-160241_ref43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3940(02)01194-1","article-title":"Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism","volume":"335","author":"Bleich","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160241_ref44","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160241_ref45","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1212\/WNL.0000000000001050","article-title":"Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT","volume":"83","author":"van der Zwaluw","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-160241_ref46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neurobiolaging.2009.02.024","article-title":"Midlife homocysteine and late-life dementia in women. A prospective population study","volume":"32","author":"Zylberstein","year":"2011","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:55Z","timestamp":1777370635000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":46,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-160241","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]}}}